Chunxiang Li - Search Results

Year	Number of Results
2003	1
2004	1
2006	2
2007	4
2008	7
2009	11
2010	18
2011	7
2012	5
2013	9
2014	16
2015	12
2016	9
2017	13
2018	18
2019	11
2020	22
2021	34
2022	25
2023	31
2024	14

1

KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells.

Zheng Y, Zhang H, Xiao C, Deng Z, Fan T, Zheng B, Li C, He J. Zheng Y, et al. Among authors: li c. J Immunother Cancer. 2023 Aug;11(8):e007286. doi: 10.1136/jitc-2023-007286. J Immunother Cancer. 2023. PMID: 37586772 Free PMC article.

2

H3K36 trimethylation-mediated biological functions in cancer.

Xiao C, Fan T, Tian H, Zheng Y, Zhou Z, Li S, Li C, He J. Xiao C, et al. Among authors: li c. Clin Epigenetics. 2021 Oct 29;13(1):199. doi: 10.1186/s13148-021-01187-2. Clin Epigenetics. 2021. PMID: 34715919 Free PMC article. Review.

3

Multiple primary lung cancer: Updates of clinical management and genomic features.

Tian H, Bai G, Yang Z, Chen P, Xu J, Liu T, Fan T, Wang B, Xiao C, Li C, Gao S, He J. Tian H, et al. Among authors: li c. Front Oncol. 2023 Feb 22;13:1034752. doi: 10.3389/fonc.2023.1034752. eCollection 2023. Front Oncol. 2023. PMID: 36910635 Free PMC article. Review.

4

TGF-β signaling in health, disease, and therapeutics.

Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, He J. Deng Z, et al. Among authors: li c. Signal Transduct Target Ther. 2024 Mar 22;9(1):61. doi: 10.1038/s41392-024-01764-w. Signal Transduct Target Ther. 2024. PMID: 38514615 Free PMC article. Review.

5

H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy.

Xiao C, Fan T, Zheng Y, Tian H, Deng Z, Liu J, Li C, He J. Xiao C, et al. Among authors: li c. J Immunother Cancer. 2023 Aug;11(8):e005693. doi: 10.1136/jitc-2022-005693. J Immunother Cancer. 2023. PMID: 37553181 Free PMC article. Review.

6

CXXC finger protein 1 (CFP1) bridges the reshaping of genomic H3K4me3 signature to the advancement of lung adenocarcinoma.

Fan T, Xiao C, Liu H, Liu Y, Wang L, Tian H, Li C, He J. Fan T, et al. Among authors: li c. Signal Transduct Target Ther. 2023 Sep 21;8(1):369. doi: 10.1038/s41392-023-01612-3. Signal Transduct Target Ther. 2023. PMID: 37735441 Free PMC article.

7

BATF reprograms the tumor immune status.

Fan T, Xiao C, Muhammad S, Li C, He J. Fan T, et al. Among authors: li c. Med. 2023 Jan 13;4(1):10-12. doi: 10.1016/j.medj.2022.12.004. Med. 2023. PMID: 36640752 Free article.

8

Bis(μ-3,5-dinitro-2-oxidobenzoato)-κO,O:O;κO:O,O-bis[aqua-(2-phenyl-1,3,7,8-tetra-azacyclo-penta-[l]phenanthrene-κN,N)cobalt(II)].

Wang XC, Chen J, Wang CJ, Li CX. Wang XC, et al. Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 5;66(Pt 7):m751-2. doi: 10.1107/S1600536810017629. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21587688 Free PMC article.

9

Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis.

Tian H, Wang Y, Yang Z, Chen P, Xu J, Tian Y, Fan T, Xiao C, Bai G, Li L, Zheng B, Li C, He J. Tian H, et al. Among authors: li c. Cancer Gene Ther. 2023 Mar;30(3):507-520. doi: 10.1038/s41417-022-00572-0. Epub 2023 Jan 19. Cancer Gene Ther. 2023. PMID: 36653483 Free PMC article.

10

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy.

Xiao C, Tian H, Zheng Y, Yang Z, Li S, Fan T, Xu J, Bai G, Liu J, Deng Z, Li C, He J. Xiao C, et al. Among authors: li c. Front Cell Dev Biol. 2022 Sep 19;10:1013885. doi: 10.3389/fcell.2022.1013885. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36200045 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

234 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Results by year